Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion

被引：5
|
作者：
Yuan, Jiaojiao [1 ]
Pei, Renzhi [1 ]
Lu, Ying [1 ]
机构：
[1] Ningbo Univ, Dept Hematol, Affiliated Peoples Hosp, Ningbo, Zhejiang, Peoples R China
来源：
TURKISH JOURNAL OF HEMATOLOGY | 2023年 / 40卷 / 01期
关键词：
Acute myeloid leukemia; NUP98-RARG; Haploidentical hematopoietic stem cell transplantation;
D O I：
10.4274/tjh.galenos.2022.2022.0475
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [41] Azacitidine maintenance after allogeneic stem cell transplantation is feasible in patients with acute myeloid leukemia and myelodysplasia
    Antar, A.
    Kharfan-Dabaja, M.
    Abou Ghaddara, H.
    Mahfouz, R.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S258 - S258
  • [42] Azacitidine Maintenance after Allogeneic Stem Cell Transplantation Is Feasible in Patients with Acute Myeloid Leukemia and Myelodysplasia
    Antar, Ahmad
    Kharfan-Dabaja, Mohamed A.
    Abou Ghaddara, Hussein
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
  • [43] Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation
    Gao, Meng-Ge
    Hong, Yan
    Qin, Ya-Zhen
    Chang, Ying-Jun
    Wang, Yu
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Huang, Xiao-Jun
    Zhao, Xiao-Su
    MEDICINE, 2020, 99 (50) : E23569
  • [44] DEK/NUP214 Fusion Gene Predicts Good Outcome In Acute Myeloid Leukemia In Complete Remission After Allogeneic Hematopoietic Stem Cell Transplantation
    Ishiyama, Ken
    Takami, Akiyoshi
    Nakao, Shinji
    Hidaka, Michihiro
    Maeda, Tetsuo
    Kawa, Keisei
    Nagamura, Tokiko
    Tabuchi, Ken
    Atsuta, Yoshiko
    Sakamaki, Hisashi
    BLOOD, 2010, 116 (21) : 988 - 989
  • [45] Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
    Zhao, Peng
    Ni, Ming
    Ma, Dan
    Fang, Qin
    Zhang, Yan
    Li, Yanju
    Huang, Yi
    Chen, Ying
    Chai, Xiao
    Zhan, Yun
    Li, Yan
    Kang, Qian
    Zhao, Mei
    Liu, Min
    Zhang, Fengqi
    Huang, Shisi
    Wen, Shuangshuang
    Deng, Bo
    Wang, Jishi
    ANNALS OF HEMATOLOGY, 2022, 101 (01) : 119 - 130
  • [46] Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
    Peng Zhao
    Ming Ni
    Dan Ma
    Qin Fang
    Yan Zhang
    Yanju Li
    Yi Huang
    Ying Chen
    Xiao Chai
    Yun Zhan
    Yan Li
    Qian Kang
    Mei Zhao
    Min Liu
    Fengqi Zhang
    Shisi Huang
    Shuangshuang Wen
    Bo Deng
    Jishi Wang
    Annals of Hematology, 2022, 101 : 119 - 130
  • [47] NUP98-HOXC13 fusion gene in acute myeloid leukemia: Pediatric case
    Goto, Hironori
    Kimura, Makoto
    Hirano, Naoki
    Suenobu, Souichi
    Ihara, Kenji
    PEDIATRICS INTERNATIONAL, 2017, 59 (10) : 1105 - 1106
  • [48] Successful Treatment of High-Risk and Refractory Acute Myeloid Leukemia with haploidentical Stem Cell Transplantation Plus NK cell therapy
    Uharek, Lutz
    Friedrichs, Birte
    Nogai, Axel
    Gentilini, Chiara
    Basara, Nadezda
    Niederwieser, Dietger
    Thiel, Eckhard
    BLOOD, 2010, 116 (21) : 982 - 982
  • [49] Haploidentical Natural Killer Cell Therapy As an Adjunct to Stem Cell Transplantation for Refractory Acute Myeloid Leukemia
    Kulkarni, Uday Prakash
    Arunachalam, Arun Kumar
    Palani, Hamenth Kumar
    Balasundaram, Nithya
    Venkatraman, Arvind
    Korula, Anu
    Devasia, Anup J.
    Na, Fouzia
    Selvarajan, Sushil
    Lionel, Sharon
    Maddali, Madhavi
    Abraham, Aby
    Balasubramanian, Poonkuzhali
    George, Biju
    Mathews, Vikram
    BLOOD, 2021, 138 : 3827 - +
  • [50] Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation
    Jones, Cortney V.
    Copelan, Edward A.
    FUTURE ONCOLOGY, 2009, 5 (04) : 559 - 568
12345